Skip to main content
Premium Trial:

Request an Annual Quote

Cuts at Some Health Tech Startups

Health tech startups are laying off or furloughing workers as they take hits from the coronavirus pandemic and related economic crisis, Stat News reports.

For instance, it reports that the healthcare billing startup Anagram has laid off 17 people, the nurse-hiring platform Incredible health has laid off nine people, and Halo Neuroscience, which is working on brain stimulation technology, has furloughed most of its 30 or so employees. "We had to pause specific markets, as hospital cancellations of elective procedures have reduced hospital revenue and slowed hiring in those specific markets," Iman Abuzeid, the CEO and co-founder of Incredible Health, tells Stat News in an email. 

Stat News says that these layoffs could be a sign that more are to come in the field, but it also notes that the field might not be uniformly affected, as it previously reported that telehealth services are experiencing an increase in demand.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.